Kimberly Chong

Array ( [id] => 6740172 [patent_doc_number] => 20030157541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Regulation of human CycLT2-like GPCR protein' [patent_app_type] => new [patent_app_number] => 10/349021 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 28687 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157541.pdf [firstpage_image] =>[orig_patent_app_number] => 10349021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865128 [patent_doc_number] => 20030190654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene' [patent_app_type] => new [patent_app_number] => 10/349320 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7114 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190654.pdf [firstpage_image] =>[orig_patent_app_number] => 10349320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702138 [patent_doc_number] => 20030225018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Syndecans and angiogenesis' [patent_app_type] => new [patent_app_number] => 10/347022 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12578 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225018.pdf [firstpage_image] =>[orig_patent_app_number] => 10347022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660389 [patent_doc_number] => 20030135033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Compounds and methods for the identification and/ or validation of a target' [patent_app_type] => new [patent_app_number] => 10/336855 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23142 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20030135033.pdf [firstpage_image] =>[orig_patent_app_number] => 10336855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483778 [patent_doc_number] => 07220853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1' [patent_app_type] => utility [patent_app_number] => 10/327509 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9771 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220853.pdf [firstpage_image] =>[orig_patent_app_number] => 10327509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846778 [patent_doc_number] => 20030165945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Human Pellino polypeptides' [patent_app_type] => new [patent_app_number] => 10/317250 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29398 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165945.pdf [firstpage_image] =>[orig_patent_app_number] => 10317250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470051 [patent_doc_number] => 20040121328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Modulation of phosphodiesterase 8A Expression' [patent_app_type] => new [patent_app_number] => 10/318389 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19936 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121328.pdf [firstpage_image] =>[orig_patent_app_number] => 10318389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289146 [patent_doc_number] => 20040110140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of CDK9 expression' [patent_app_type] => new [patent_app_number] => 10/315765 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20014 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110140.pdf [firstpage_image] =>[orig_patent_app_number] => 10315765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833632 [patent_doc_number] => 07396922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Regulation of hypoxia-inducible gene expression with antisense Inhibitory PAS domain protein' [patent_app_type] => utility [patent_app_number] => 10/496945 [patent_app_country] => US [patent_app_date] => 2002-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 4770 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396922.pdf [firstpage_image] =>[orig_patent_app_number] => 10496945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083267 [patent_doc_number] => 20050048647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Sirna expression system and process for producing functional gene knockdown cell or the like using the same' [patent_app_type] => utility [patent_app_number] => 10/470197 [patent_app_country] => US [patent_app_date] => 2002-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 16791 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048647.pdf [firstpage_image] =>[orig_patent_app_number] => 10470197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669427 [patent_doc_number] => 20030114411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Stable alteration on pre-mRNA splicing patterns by modified RNAs' [patent_app_type] => new [patent_app_number] => 10/306294 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114411.pdf [firstpage_image] =>[orig_patent_app_number] => 10306294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660172 [patent_doc_number] => 20030134816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Therapeutic compounds' [patent_app_type] => new [patent_app_number] => 10/300575 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8866 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134816.pdf [firstpage_image] =>[orig_patent_app_number] => 10300575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474166 [patent_doc_number] => 20040097446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of checkpoint kinase 1 expression' [patent_app_type] => new [patent_app_number] => 10/298994 [patent_app_country] => US [patent_app_date] => 2002-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23391 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097446.pdf [firstpage_image] =>[orig_patent_app_number] => 10298994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851535 [patent_doc_number] => 20030143738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Compositions and methods for treating ischemic stroke' [patent_app_type] => new [patent_app_number] => 10/291046 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10422 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143738.pdf [firstpage_image] =>[orig_patent_app_number] => 10291046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711571 [patent_doc_number] => 20030171320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Methods for treating ocular neovascular diseases' [patent_app_type] => new [patent_app_number] => 10/291091 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11910 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171320.pdf [firstpage_image] =>[orig_patent_app_number] => 10291091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797510 [patent_doc_number] => 20030176384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Antisense oligonucleotides for the inhibition of integrin alphav -subunit expression' [patent_app_type] => new [patent_app_number] => 10/288567 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17748 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176384.pdf [firstpage_image] =>[orig_patent_app_number] => 10288567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635329 [patent_doc_number] => 20030211608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense modulation of glycogen synthase kinase 3 beta expression' [patent_app_type] => new [patent_app_number] => 10/181543 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23493 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211608.pdf [firstpage_image] =>[orig_patent_app_number] => 10181543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791951 [patent_doc_number] => 20030087295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Methods and compositions for the treatment and diagnosis of pain disorders using 9805' [patent_app_type] => new [patent_app_number] => 10/282942 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24971 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087295.pdf [firstpage_image] =>[orig_patent_app_number] => 10282942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740723 [patent_doc_number] => 20030158092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality' [patent_app_type] => new [patent_app_number] => 10/148587 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4409 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158092.pdf [firstpage_image] =>[orig_patent_app_number] => 10148587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6646153 [patent_doc_number] => 20030104352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Methods for analyzing the insertion capabilities of modified group II introns' [patent_app_type] => new [patent_app_number] => 10/277643 [patent_app_country] => US [patent_app_date] => 2002-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13579 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104352.pdf [firstpage_image] =>[orig_patent_app_number] => 10277643 [rel_patent_id] =>[rel_patent_doc_number] =>)